HDAC inhibitors can directly inhibit tumor cell proliferation as a result of inducing cell cycle arrest and apoptosis through epigenetic effects on gene expression and by interfering with T-cell chemotaxis in the tumor microenvironment [26]. Here, HDAC9 is linked to neoplasm.